Connection

Allison Eckard to Humans

Back to Details
This is a "connection" page, showing publications Allison Eckard has written about Humans.
Allison Eckard
Connection Strength
0.605
Humans
  1. Remestemcel-L Therapy for COVID-19-Associated Multisystem Inflammatory Syndrome in Children. Pediatrics. 2021 05; 147(5).
    View in: PubMed
    Score: 0.029
  2. Fecal Calprotectin Is Elevated in HIV and Related to Systemic Inflammation. J Acquir Immune Defic Syndr. 2021 02 01; 86(2):231-239.
    View in: PubMed
    Score: 0.029
  3. Fibroblast Growth Factor 21 Is Elevated in HIV and Associated With Interleukin-6. J Acquir Immune Defic Syndr. 2020 04 15; 83(5):e30-e33.
    View in: PubMed
    Score: 0.027
  4. Weight gain and integrase inhibitors. Curr Opin Infect Dis. 2020 02; 33(1):10-19.
    View in: PubMed
    Score: 0.027
  5. Contemporary Issues in Pregnancy (and Offspring) in the Current HIV Era. Curr HIV/AIDS Rep. 2019 12; 16(6):492-500.
    View in: PubMed
    Score: 0.026
  6. Vitamin D supplementation decreases immune activation and exhaustion in HIV-1-infected youth. Antivir Ther. 2018; 23(4):315-324.
    View in: PubMed
    Score: 0.023
  7. Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-Infected Youth. J Acquir Immune Defic Syndr. 2017 12 15; 76(5):539-546.
    View in: PubMed
    Score: 0.023
  8. Effects of vitamin D supplementation on carotid intima-media thickness in HIV-infected youth. Virulence. 2018 01 01; 9(1):294-305.
    View in: PubMed
    Score: 0.023
  9. Arterial stiffness in HIV-infected youth and associations with HIV-related variables. Virulence. 2017 10 03; 8(7):1265-1273.
    View in: PubMed
    Score: 0.022
  10. Amino Acid Concentrations in HIV-Infected Youth Compared to Healthy Controls and Associations with CD4 Counts and Inflammation. AIDS Res Hum Retroviruses. 2017 07; 33(7):681-689.
    View in: PubMed
    Score: 0.022
  11. Effects of cholecalciferol supplementation on serum and urinary vitamin D metabolites and binding protein in HIV-infected youth. J Steroid Biochem Mol Biol. 2017 04; 168:38-48.
    View in: PubMed
    Score: 0.022
  12. Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation. Antivir Ther. 2017; 22(8):669-680.
    View in: PubMed
    Score: 0.022
  13. Increased Immune Activation and Exhaustion in HIV-infected Youth. Pediatr Infect Dis J. 2016 12; 35(12):e370-e377.
    View in: PubMed
    Score: 0.021
  14. Cardiovascular Disease, Statins, and HIV. J Infect Dis. 2016 Oct 01; 214 Suppl 2:S83-92.
    View in: PubMed
    Score: 0.021
  15. Kallistatin levels in HIV-infected patients and effects of statin therapy. Biomarkers. 2017 Feb; 22(1):55-62.
    View in: PubMed
    Score: 0.021
  16. Complications of Treatment in Youth with HIV. Curr HIV/AIDS Rep. 2016 08; 13(4):226-33.
    View in: PubMed
    Score: 0.021
  17. Bone health in HIV-infected children and adolescents. Curr Opin HIV AIDS. 2016 May; 11(3):294-300.
    View in: PubMed
    Score: 0.021
  18. The role of statins in the setting of HIV infection. Curr HIV/AIDS Rep. 2015 Sep; 12(3):305-12.
    View in: PubMed
    Score: 0.020
  19. Vitamin D deficiency and altered bone mineral metabolism in HIV-infected individuals. Curr HIV/AIDS Rep. 2014 Sep; 11(3):263-70.
    View in: PubMed
    Score: 0.018
  20. Habitual nutrient intake in HIV-infected youth and associations with HIV-related factors. AIDS Res Hum Retroviruses. 2014 Sep; 30(9):888-95.
    View in: PubMed
    Score: 0.018
  21. LL-37 concentrations and the relationship to vitamin D, immune status, and inflammation in HIV-infected children and young adults. AIDS Res Hum Retroviruses. 2014 Jul; 30(7):670-6.
    View in: PubMed
    Score: 0.018
  22. Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy. J Infect Dis. 2014 Apr 15; 209(8):1156-64.
    View in: PubMed
    Score: 0.018
  23. The relationship between vitamin D status and HIV-related complications in HIV-infected children and young adults. Pediatr Infect Dis J. 2013 Nov; 32(11):1224-9.
    View in: PubMed
    Score: 0.017
  24. Short communication: High prevalence of vitamin D deficiency in HIV-infected and HIV-uninfected pregnant women. AIDS Res Hum Retroviruses. 2013 Sep; 29(9):1224-8.
    View in: PubMed
    Score: 0.017
  25. Risk factors for vitamin D deficiency and relationship with cardiac biomarkers, inflammation and immune restoration in HIV-infected youth. Antivir Ther. 2012; 17(6):1069-78.
    View in: PubMed
    Score: 0.016
  26. Optimizing tobacco treatment delivery for people with HIV: trial protocol for a randomized controlled trial. Addict Sci Clin Pract. 2022 Nov 05; 17(1):61.
    View in: PubMed
    Score: 0.008
  27. Optimizing the Implementation of Tobacco Treatment for People with HIV: A Pilot Study. Int J Environ Res Public Health. 2022 Oct 08; 19(19).
    View in: PubMed
    Score: 0.008
  28. Obesity and Fat Metabolism in Human Immunodeficiency Virus-Infected Individuals: Immunopathogenic Mechanisms and Clinical Implications. J Infect Dis. 2019 07 02; 220(3):420-431.
    View in: PubMed
    Score: 0.006
  29. Increased influenza-specific antibody avidity in HIV-infected women compared with HIV-infected men on antiretroviral therapy. AIDS. 2019 01 27; 33(1):33-44.
    View in: PubMed
    Score: 0.006
  30. Elevated systemic microbial translocation in pregnant HIV-infected women compared to HIV-uninfected women, and its inverse correlations with plasma progesterone levels. J Reprod Immunol. 2018 06; 127:16-18.
    View in: PubMed
    Score: 0.006
  31. Efavirenz and ritonavir-boosted lopinavir use exhibited elevated markers of atherosclerosis across age groups in people living with HIV in Ethiopia. J Biomech. 2016 09 06; 49(13):2584-2592.
    View in: PubMed
    Score: 0.005
  32. Statins to improve cardiovascular outcomes in treated HIV infection. Curr Opin Infect Dis. 2016 Feb; 29(1):1-9.
    View in: PubMed
    Score: 0.005
  33. Bone loss in HIV: a contemporary review. Curr Opin Endocrinol Diabetes Obes. 2015 Dec; 22(6):446-51.
    View in: PubMed
    Score: 0.005
  34. Missed opportunities for prevention of mother-to-child transmission in the United States. AIDS. 2015 Jul 31; 29(12):1511-5.
    View in: PubMed
    Score: 0.005
  35. Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age. J Pediatric Infect Dis Soc. 2015 Sep; 4(3):214-24.
    View in: PubMed
    Score: 0.005
  36. Metabolic complications and treatment of perinatally HIV-infected children and adolescents. J Int AIDS Soc. 2013 Jun 18; 16:18600.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.